Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1Classical hematology 1

Conditions

Patient Participation 1Multiple Myeloma 1Lymphoma 1Febrile Neutropenia 1

Interventions

Cyclophosphamide 37fludarabine phosphate 31Busulfan 25Antilymphocyte Serum 22Mycophenolic Acid 20Melphalan 19Cyclosporine 19Peripheral Blood Stem Cell Transplantation 16Filgrastim 16Cord Blood Stem Cell Transplantation 16Whole-Body Irradiation 14Tacrolimus 14Radiotherapy 14Methylprednisolone 13fludarabine 11Methotrexate 8Epoetin Alfa 8Etoposide 7Cytarabine 7Thiotepa 6Alemtuzumab 6thymoglobulin 4Granulocyte Colony-Stimulating Factor 4Darbepoetin alfa 3Bone Marrow Transplantation 3Stem Cell Transplantation 2Sirolimus 2Rituximab 2Mesna 2Influenza Vaccines 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma × TKN732 × Classical hematology × Clear all
NCT06116734 2023-11-03

Lapelga vs Gastrofil

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Unknown
74 enrolled
Classical hematologyLymphoidPlasma cell

Lymphoma, Multiple Myeloma, Patient Participation, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡